The U.S. Justice Department reached a settlement with Johnson & Johnson, which is the maker of Risperdal. The settlement of $2.2 billion and a misdemeanor plea comes after a long investigation into the marketing of the pharmaceutical product, Risperdal. It is an anti-psychotic drug known to deliver harmful side effects, especially to young boys and young men most often prescribed the medicine.
In this case, the Department of Justice engaged several whistleblowers around the country to help the investigation and act as Johnson & Johnson informants. In fact, collectively, the whistleblowers will receive upwards of $167 million for their efforts.
The whistleblowers took great risk in assisting the Department of Justice in this investigation. Some of the whistleblowers went undercover, wore a wire, helped in prepping the department lawyers for depositions and otherwise risked their livelihood and their careers.